Poor mobilization is an independent prognostic factor in patients with malignant lymphomas treated by peripheral blood stem cell transplantation (Q82735571)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 April 2006

Language	Label	Description	Also known as
English	Poor mobilization is an independent prognostic factor in patients with malignant lymphomas treated by peripheral blood stem cell transplantation	scientific article published on 01 April 2006

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16518434%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Poor mobilization is an independent prognostic factor in patients with malignant lymphomas treated by peripheral blood stem cell transplantation (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16518434%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

stem cell transplantation

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16518434%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Attilio Guarini

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16518434%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Pavone V

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16518434%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Gaudio F

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16518434%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Console G

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16518434%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Iacopino P

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16518434%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Liso V

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16518434%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Perrone T

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16518434%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Liso A

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16518434%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

1 April 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16518434%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16518434%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

37

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16518434%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16518434%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

719-724

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16518434%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705298

0 references

Autologous bone marrow and peripheral blood stem cell transplantation in haematological malignancies: current status

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705298

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic peripheral blood stem cell transplantation for high-risk non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705298

7 January 2021

based on heuristic

inferred from DOI database lookup

Progressive disease following autologous transplantation in patients with chemosensitive relapsed or primary refractory Hodgkin's disease or aggressive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705298

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705298

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705298

7 January 2021

based on heuristic

inferred from DOI database lookup

Peripheral blood vs bone marrow as a source for allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705298

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparative study of peripheral blood stem cell vs bone marrow transplantation from unrelated donors (MUD): a single center study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705298

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of peripheral blood progenitor cell vs bone marrow as hematopoietic support for high-dose chemotherapy in patients with non-Hodgkin's lymphoma and Hodgkin's disease: a clinical and molecular analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705298

7 January 2021

based on heuristic

inferred from DOI database lookup

Peripheral-blood stem-cell transplantation versus autologous bone marrow transplantation in Hodgkin's and non-Hodgkin's lymphomas: a new matched-pair analysis of the European Group for Blood and Marrow Transplantation Registry Data. Lymphoma Working

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705298

7 January 2021

based on heuristic

inferred from DOI database lookup

Peripheral stem cell transplantation in non-Hodgkin's lymphoma patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705298

7 January 2021

based on heuristic

inferred from DOI database lookup

Stem cell mobilization.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705298

7 January 2021

based on heuristic

inferred from DOI database lookup

Mobilization of peripheral blood stem cells with high-dose cyclophosphamide or the DHAP regimen plus G-CSF in non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705298

7 January 2021

based on heuristic

inferred from DOI database lookup

Stem cell mobilisation in lymphoproliferative diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705298

7 January 2021

based on heuristic

inferred from DOI database lookup

Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705298

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical significance of CD34+ cell dose in long-term engraftment following autologous peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705298

7 January 2021

based on heuristic

inferred from DOI database lookup

Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705298

7 January 2021

based on heuristic

inferred from DOI database lookup

Engraftment and outcomes of patients receiving myeloablative therapy followed by autologous peripheral blood stem cells with a low CD34+ cell content

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705298

7 January 2021

based on heuristic

inferred from DOI database lookup

Large‐volume leukapheresis using femoral venous access for harvesting peripheral blood stem cells with the Fenwal CS 3000 Plus from normal healthy donors: Predictors of CD34+ cell yield and collection efficiency

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705298

7 January 2021

based on heuristic

inferred from DOI database lookup

When to harvest peripheral-blood stem cells after mobilization therapy: prediction of CD34-positive cell yield by preceding day CD34-positive concentration in peripheral blood

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705298

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors associated with successful mobilization of peripheral blood progenitor cells in 200 patients with lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705298

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors that influence the collection and engraftment of allogeneic peripheral-blood stem cells in patients with hematologic malignancies.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705298

7 January 2021

based on heuristic

inferred from DOI database lookup

The minimum CD34 threshold depends on prior chemotherapy in autologous peripheral blood stem cell recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705298

7 January 2021

based on heuristic

inferred from DOI database lookup

Progenitor cell yields are frequently poor in patients with histologically indolent lymphomas especially when mobilized within 6 months of previous chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705298

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose ara-C with autologous peripheral blood progenitor cell support induces a marked progenitor cell mobilization: an indication for patients at risk for low mobilization.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705298

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of rituximab on peripheral blood stem cell mobilization and engraftment kinetics in non-Hodgkin's lymphoma patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705298

7 January 2021

based on heuristic

inferred from DOI database lookup

Peripheral blood stem cell mobilization following CHOP plus rituximab therapy combined with G-CSF in patients with B-cell non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705298

7 January 2021

based on heuristic

inferred from DOI database lookup

Poor mobilization of peripheral blood stem cells is a risk factor for worse outcome in lymphoma patients undergoing autologous stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705298

7 January 2021

based on heuristic

inferred from DOI database lookup

Favorable treatment outcome in non-Hodgkin's lymphoma patients with "poor" mobilization of peripheral blood progenitor cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705298

7 January 2021

based on heuristic

inferred from DOI database lookup

A Low CD34+ Cell Dose Predicts Relapse and Death Early following Autologous Blood Stem Cell Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705298

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of recombinant human growth hormone (rhGH) plus recombinant human granulocyte colony-stimulating factor (rhG-CSF) for the mobilization and collection of CD34+ cells in poor mobilizers.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705298

7 January 2021

based on heuristic

inferred from DOI database lookup

The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705298

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q82735571&oldid=1753710957"